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ABSTRACT High sensitivity differential scanning calorimetry (DSC) was used to investigate the thermotropic phase prop-
erties of binary mixtures of disaturated phosphocholines (PCs) and -bromoacyl taxane derivatives. The -bromoacyl taxanes
were synthesized as hydrolyzable hydrophobic prodrugs of paclitaxel. The PCs used were 1,2-dimyristoyl-sn-glycero-3-
phosphatidyl-choline (DMPC), 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) and 1,2-distearoyl-sn-glycero-3-
phosphatidylcholine (DSPC). The bromoacyl chain lengths of the taxane prodrugs were varied from 6 to 12 or 16 carbons. For
comparison, paclitaxel and PC mixtures were also examined. DSC data from DPPC and bromoacyl taxane mixtures showed
a complete abolition of the pretransition and significant broadening of the main phase transition with increasing amounts of
bromoacyl taxane prodrugs. The effects were more pronounced with the long-chain compared to the short-chain prodrugs.
Under equivalent DSC conditions, the short-chain DMPC showed greater changes in thermotropic phase behavior than with
DPPC on taxane addition, suggesting an enhanced degree of association with the fluid-type bilayers. Under similar
conditions, the long-chain DSPC bilayers showed a far less significant change in phase behavior on taxane addition than
DPPC. These changes were also chain length-dependent for both the PCs and the taxane prodrugs. In contrast, PC and
paclitaxel (lacking the acyl chain) mixtures under similar conditions showed insignificant changes in the endotherms,
suggesting only slight insertion of the molecule into the PC bilayers. From the DSC data it is apparent that taxane prodrugs
solvated in DMPC bilayers more than in DPPC and DSPC bilayers, and taxane prodrugs with longer acyl chains were able to
associate with PCs better than those with shorter chain prodrugs. DSC data also suggest that paclitaxel was poorly
associated with any of the PCs. In general, the amount of taxane association with bilayers decreased in order: DMPC 
DPPC  DSPC. In contrast, the transition enthalpy (H) of DMPC, DPPC, and DSPC mixtures with paclitaxel showed
significantly lower enthalpies than with taxane prodrugs. Taken together, the DSC data suggest that the acyl chains of
paclitaxel prodrugs have some access into the bilayers via alignment with the acyl chain of the PC component.
INTRODUCTION
Paclitaxel formulated in Cremophor EL as Taxol is used for
the treatment of several types of cancer (for reviews, see
Straubinger, 1995; Suffness, 1993). Taxol causes side ef-
fects in humans (Woodburn and Kessel, 1994; Weiss et al.,
1990) and, although these effects are clinically manageable,
there is a continued interest in finding excipients that can be
administered easily and safely.
There is an interest from other laboratories in finding
paclitaxel prodrugs with increased water solubility, low
acute toxicity, and yet therapeutic efficacy. Water-soluble
paclitaxel derivatives have been prepared and their struc-
ture-activity relationships have been investigated (Li et al.,
1996; Greenwald et al., 1994; Deutsch et al., 1989). Some of
these derivatives have anticancer activities in animals sim-
ilar to those of paclitaxel (Rose et al, 1997). Alternatively,
paclitaxel alone has been encapsulated in biodegradable
polymers (Zhang et al., 1996; Sharma et al., 1996; Burt et
al., 1995) and associated with liposomes, micelles, and
emulsions in attempt to reduce the toxic effects of Taxol
(Sharma et al., 1993; Tarr et al., 1987). However, the
amount of paclitaxel that can be incorporated into lipid
bilayers is limited (Sharma et al., 1998; Shieh et al., 1997;
Balasubramanian and Straubinger, 1994). It is therefore of
interest to investigate the interactions of lipid-based pro-
drugs into lipid bilayers.
A prodrug is defined as a pharmacologically inactive
compound that is activated upon exposure into the biolog-
ical environments (Silverman, 1992). As shown in Eq. 1, the
hydroxyl group of a drug can be functionalized with a
cleavable ligand or carrier-linked, which in turn could be
hydrolyzed by chemical and/or enzymatic means. When the
prodrug is administered the aim is to release the drug more
efficiently and effectively at its site of action, reducing
toxicity and enhancing activity compared with the parent
molecule.
Drug-OH ¡ Drug-OAc ¡ Drug-OH
(1)
Prodrug inactive in vivo
We initiated an effort to synthesize prodrugs of paclitaxel of
the lipophilic nature that were approximately as active as
paclitaxel in vivo, and that could lead to a greater degree of
association with PC bilayers than the parent molecule. Thus,
we synthesized a series of prodrugs with -bromine substi-
tuted acyl chains at the 2-position of the C-13 paclitaxel
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side chain. The aim was that the heteroatom at the -posi-
tion would facilitate the hydrolysis of the hydrophobic chain
in the biological environment with release of paclitaxel in
the tumor site (Mayhew et al., 1997). Here we report the
mixing behavior of paclitaxel and its bromoacylated C-6,
C-12, and C-16 derivatives with PCs liposomes using dif-
ferential scanning calorimetry (DSC). Liposomes were
formed from DMPC, DPPC, and DSPC, which had satu-
rated di-C-14:0, di-C-16:0, and di-C-18:0 acyl chains, re-
spectively. DSC data from the present study indicate that PC
liposomes had limited ability to accommodate paclitaxel
because of its bulky taxane structure. From the data it is also
clear that the preferential association of modified paclitaxels
with hydrophobic moieties varied with the PC’s bilayer
compositions and the prodrug’s acyl chain lengths. Further-
more, the DSC results suggest that relatively long acyl
chains attached to the taxane may facilitate a greater degree
of association with fluid-type rather than gel-type bilayers
and may, therefore, assist in increasing the amount of pro-
drug association with the PC’s bilayers. Although the mech-
anism of paclitaxel interactions with phospholipid mem-
branes is poorly understood (Balasubramanian and
Straubinger, 1994; Wenk et al., 1996), this report sheds light
on how acylated taxane prodrugs may interact with model
and biological membranes.
MATERIALS AND METHODS
Paclitaxel of purity 99%, was purchased from Hauser Chemical Re-
search, Inc. (Boulder, CO). 1,2-Dimyristoyl-sn-glycero-3-phosphatidyl-
choline (DMPC), 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine
(DPPC), and 1,2-distearoyl-sn-glycero-3-phosphatidylcholine (DSPC)
were from Nippon Oil and Fats Co. Ltd. (Japan). DSPC was also purchased
from Sigma (St. Louis, MO). The -bromofatty acids were from either
Aldrich or Fluka Chemicals. 1,3-Dicyclohexylcarbodiimide (DCC) and
4-dimethylamino-pyridine (DMAP) were obtained from Fluka and used
without purification. The products were purified using preparative thin
layer chromatography (TLC) plate (1000 , Analtech, Newark, DE) using
CHCl3:MeOH (95:5) or EtOAc:Hexane (40:60).
Synthesis
Scheme I shows the general route to the synthesis of -bromoacyl taxane
prodrugs.
General procedure for the preparation of
2-()-()-bromohexanoyl taxane
Paclitaxel (500 mg, 0.586 mmol) and the catalyst 4-dimethylaminopyridine
(71.5 mg, 0.586 mmol) were added to a 10 min stirred solution of
()--bromohexanoic acid (229 mg, 1.17 mmol) and 1,3-dicyclohexylcar-
bodiimide (241 mg, 1.17 mmol) in 30 ml of dry CH2Cl2. After 5 min of
reaction, the white precipitate of dicyclohexyl urea was filtered through a
Celite pad. The filtrate was evaporated under vacuo and the residue
obtained was purified by preparative TLC in CHCl3:MeOH (95:5) to give
the desired product (Rf 0.58). After passing through a Metricel filter (0.1
) to remove fine silica gel from CHCl3 solution, the product was lyo-
philized from cyclohexane to yield 507 mg (84%) as a white solid. 1H
NMR (CDCl3, 300 MHz) chemical shifts of some of the characteristic
peaks at  (in ppm) were: 8.14 (d, J  7.3 Hz, 2H, aromatic), 7.72 (d, J 
7.3 Hz, 2H, aromatic), 7.61 (m, 1H, aromatic), 7.54–7.48 (m, 3H, aromatic),
7.42–7.36 (m, 7H, aromatic), 6.87 (dd, J  2.4 Hz, 3.4 Hz, 1H, NH), 6.29
(m, 2H, H-10 and H-13), 6.0 (m, 1H, H-3) 5.68 (d, J  6.9 Hz, 1H, H-2b),
5.50 (dd, J 1.4 Hz, 1.0 Hz, 1H, H-2), 4.97 (d, J 7.8 Hz, 1H, H-5), 4.45
(m, 1H, H-7), 4.32 (d, J  7.3 Hz, 1H, H-20a), 4.28 (m, 1H, CH(Br)), 4.20
(d, J  8.3 Hz, 1H, H-20b), 4.0 (br, OH), 3.81 (d, J  6.9 Hz, 1H, H-3),
0.86 (app. t. 3H, -CH3). FABMS: (M.H)
	 1030. Analysis calculated for
C53H60O15NBr.0.5 H2O: C, 61.21; H, 5.91; N, 1.34; Found: C, 61.35; H,
5.72; N, 1.96.
Scheme I.
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2-()-()-Bromododecanoyl (C-12) and bromohexadecanoyl (C-16)
taxane prodrugs were prepared (in 80–90% yield) using the procedure as
described above and were identified by 1H NMR, mass spectral, and
elemental analyses.
Liposome preparations
Stock solutions of taxol derivatives and phospholipids were prepared and
stored in chloroform at 
20°C. The phospholipid concentration was de-
termined by the procedure of Bartlett (1959). For preparation of liposomes,
aliquots of stock solutions of mixtures of each component were thoroughly
mixed in 10-ml tubes, and CHCl3 was evaporated under a stream of
nitrogen gas (N-EVAP). The resulting thin film was dried under vacuum
for several hours and then hydrated with 150 mM NaCl or PBS buffer at
pH 7.4, unless indicated otherwise. The mixture was vortexed and was
heated (above the phase transition temperatures of the lipids) and cooled
(0°C) several times. The resulting multilamellar vesicles (MLVs) were
used in the subsequent experiments. The sucrose gradient column (Perkins,
personal communication) and gel exclusion column (Qiu and Pidgeon,
1994) were performed to separate C-16 taxane-associated liposomes from
free prodrug. The samples for the column chromatography were prepared
in the same manner as those prepared for the DSC run.
Differential scanning calorimetry (DSC)
High resolution DSC measurements were performed using an MC-2 cal-
orimeter (MicroCal, Amherst, MA) equipped to perform ascending and
descending temperature mode operations. The lipid concentration used was
4–5 mg/ml and the temperature of the sample and reference cells was
controlled by a circulating water bath. The scan rate was 20°C/hr for both
heating and cooling scans. Data were analyzed using ORIGIN software
provided by MicroCal. After DSC run the samples were checked for
decomposition by TLC. No decomposition was observed. Samples were
scanned several times to ensure the reproducibility of the endotherms.
RESULTS
The aim of this study was to investigate how paclitaxel and
its bromoacylated taxane prodrugs affect the thermotropic
phase behavior and packing of the bilayers in model mem-
branes. As DSC data from the heating curves reflected
essentially the same changes as those from the cooling
curves, only endothermic curves were used to characterize
the thermotropic phase transitions of the binary mixtures of
PCs and paclitaxel or bromoacyl taxane prodrugs.
The effects of paclitaxel addition on
DMPC bilayers
Fig. 1 shows the endothermic phase transitions for binary
mixtures of DMPC and paclitaxel. The multilamellar bilay-
ers of DMPC alone (curve a) showed a pretransition at
13.1°C (T1/2  1.9°C and H  1.1 kcal/mol) and a main
phase transition (Tm) at 23.2°C (T1/2  0.4°C and H 
7.1 kcal/mol). The pretransition indicates a transformation
from a tilted to a rippled chain gel phase (L3 P) and at
the Tm there is a transformation from the gel to the liquid
crystalline phase (P3 L). In general, paclitaxel addition
in the range investigated (from 1 to 9.1 mol%) caused some
degree of perturbation in the DMPC bilayers. At 1 mol%
paclitaxel addition the pretransition broadened but did not
disappear and was shifted to a lower temperature ( 8°C),
while the main transition temperature was shifted slightly to
a lower temperature (22.8°C) and remained symmetric
(curve b). At 3 mol% paclitaxel, the pretransition disap-
peared and the main phase transition was broadened signif-
icantly with a broad shoulder at a lower temperature
(21°C) and a distinct sharp peak at a higher temperature
(22°C) (curve c). This change in the main transition was
reproducible independent of sample preparations. This re-
sult clearly indicates that there may be complex formation
or inhomogeneous mixing of paclitaxel with DMPC. At 4.8
mol% paclitaxel concentration in DMPC, the endotherm
was sharp and symmetrical with a noticeable pretransition
(curve d), essentially the same as curve b. Increasing
amount of paclitaxel to 9.1 mol%, however, progressively
shifted the endotherm (curve e) in pretransition to a lower
temperature. The main phase transition temperature, how-
ever, remained symmetrical, suggesting that paclitaxel had a
limited access to bilayer interiors at higher concentrations.
The effects of -bromoacyl taxane prodrugs
addition on DMPC bilayers
Fig. 2A shows the endothermic DSC profile for binary
mixtures of DMPC and C-6 taxane. In general, all the DSC
FIGURE 1 The DSC endotherms of binary mixtures of DMPC with
varying amounts (in mol%) of paclitaxel: 0 (curve a), 1 (curve b), 3 (curve
c), 4.8 (curve d), and 9.1 (curve e).
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endotherms showed addition of taxane to DMPC bilayers
caused a broadening and a decrease in the peak height of the
of main phase transition of DMPC. For example, addition of
taxane at concentrations of 1 to 3 mol% nearly abolished the
pretransition and lowered the main transition temperature
(curves b and c). Furthermore, the shape of endotherms
remained broad and symmetric, suggestive of ideal mixing.
At C-6 taxane concentrations of 4.8 mol%, the pretransition
completely disappeared and the lamellar phase transition
broadened further (curve d). Addition of C-6 taxane at
concentrations 9.1 mol% (highest concentration used) re-
sulted in a similar change (curve e) as the curve d except the
endotherm was broadened further.
Increasing the taxane acyl chain length to 12 carbons
increased association with DMPC (Fig. 2 B). The addition
of C-12 taxane to DMPC caused a significant broadening of
the gel to liquid crystalline lamellar phase transition. For
example, the addition of C-12 taxane at as little as 1 mol%
(curve b) nearly abolished the pretransition and significantly
broadened the main phase transition. At 3 mol%, the pre-
transition was completely abolished and the main phase
transition had two inseparable peaks (curve c) at about
24°C, 1°C apart, indicative of an initiation of inhomoge-
neous mixing and possibly of the phase separation in the gel
phase. Increasing the taxane content to 4.8 mol% resulted in
coalescence of the two separate peaks into a relatively broad
peak with a low temperature shoulder at 21°C (curve d).
At 9.1 mol% taxane the endotherm was further broadened
and there was a low temperature shoulder at 21°C (curve
e). At taxane concentrations 16.7 mol% no further change in
the endotherm was observed (curve f), suggesting that the
broadening was saturable at or above 9 mol%.
Like C-12 taxane, C-16 taxane addition in DMPC (Fig. 2
C) resulted in the same changes in endotherms as those
shown in Fig. 2B. Accordingly, increasing amounts of C-16
taxane (ranging from 1 to 3 mol%) showed an endotherm
with T1/2  1.75°C comparable to a T1/2  1.7°C for
C-12 taxane at the equivalent concentrations (curves c, Fig.
2 C vs. 2 B). With an increase in C-16 taxane to 4.8 mol%,
the T1/2 increased to 3°C, comparable to T1/2  2.5°C
for C-12 taxane (Fig. 2 B). With further increases in C-16
taxane to 9.1 mol% and 16.7 mol%, there was no apparent
change in the shape of the endotherms with T1/2  5–6°C
(curves e and f, Fig. 2 C), the same as those observed for
C-12 taxane at equivalent concentrations (Fig. 2 B). At
higher taxane concentrations (9.1 mol% and above), the
endotherms remained broad with shoulders at temperature
slightly higher than DMPC main phase transition, probably
indicating the saturation level of C-16 taxane in DMPC with
inhomogeneous mixing or domain formation.
Similar experiments to those described for DMPC were
carried out using DPPC and DSPC.
The effects of paclitaxel addition on
DPPC bilayers
Fig. 3 shows the DSC endothermic profile for binary mix-
tures of DPPC and paclitaxel. DPPC alone (curve a) showed
endotherm comprised of a pretransition (L 3 P) at
34.5°C (T1/2  1.9°C and H  1.97 kcal/mol), and a
P 3 L main phase transition (Tm) at 42°C (T1/2 
0.25°C and H  8.5 kcal/mol). At 1 mol% paclitaxel
addition (curve b), the pretransition and the main phase
FIGURE 2 The DSC endotherms of binary mixtures of DMPC with varying amounts (in mol%) of bromoacyl taxane prodrugs: 0 (curve a), 1 (curve b),
3 (curve c), 4.8 (curve d), 9.1 (curve e), and 16.7 (curve f). (A) DMPC and C-6 taxane; (B) DMPC and C-12 taxane; (C) DMPC and C-16 taxane mixtures.
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transitions were significantly broadened. At 3 to 4.8 mol%,
the pretransition was abolished and the main phase transi-
tion remained symmetric (curves c and d). At paclitaxel
concentration 9.1 mol% the main phase transition remained
symmetric and relatively sharp (curve e), indicating at all
concentrations the bilayers were less perturbed, probably
due to lack of DPPC ability to solvate paclitaxel. Interest-
ingly, at low mol% of paclitaxel, the DPPC was less per-
turbed compared to DMPC (Fig. 3 vs. Fig. 1). The data
suggests that, unlike DPPC, DMPC fluid-type bilayers al-
low some access for intrusion of part of the paclitaxel
molecule but not for the ideal mixing. It is possible that
paclitaxel at 1 to 4.8 mol% in DPPC preferentially favors
the phase-separated domains at the membrane-water inter-
face with little or no influence on the bilayers phase behav-
ior. However, at higher mol% DPPC showed a similar effect
as observed with DMPC under equivalent conditions, where
the endotherms were far less perturbed but remained sym-
metric (Figs. 1 and 3) with reduced transition enthalpy
(H).
The effects of -bromoacyl taxane prodrugs
addition on DPPC bilayers
Fig. 4 A shows the DSC profile for the binary mixtures of
DPPC and C-6 taxane. Like DMPC/C-6 taxane mixtures
(Fig. 2 A), the addition of C-6 taxane into DPPC at concen-
trations 1–3 mol% abolished the pretransition. The main
phase transition remained broad and symmetric (curves b
and c). As the taxane increased to 4.8 mol% (curve d), the
main phase transition was broadened further but remained
symmetric. Increasing C-6 taxane content to 9.1 or 16.7
mol% (curves e and f) did not influence the main phase
transition, indicating a lesser tendency of DPPC than
DMPC in accommodating C-6 taxane, in part, due to a
strong lateral chain-chain interaction in the bilayers.
FIGURE 3 The DSC endotherms of binary mixtures of DPPC with
varying amounts (in mol%) of paclitaxel: 0 (curve a), 1 (curve b), 3 (curve
c), 4.8 (curve d), and 9.1 (curve e).
FIGURE 4 The DSC endotherms of binary mixtures of DPPC with varying amounts (in mol%) of bromoacyl taxane prodrugs: 0 (curve a), 1 (curve b),
3 (curve c), 4.8 (curve d), 9.1 (curve e), and 16.7 (curve f). (A) DPPC and C-6 taxane; (B) DPPC and C-12 taxane; (C) DPPC and C-16 taxane mixtures.
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The DSC profile for mixtures of DPPC and C-12 taxane
is shown in Fig. 4 B. At low concentrations, the effects of
C-12 taxane on the DPPC were the same as for DMPC and
C-12 taxane mixtures (Fig. 2 B). For instance, prodrug
addition at 1–3 mol% (curves b and c) abolished the pre-
transition and broadened the main phase transition, sugges-
tive of a noncooperative and inhomogeneous mixing of
C-12 taxane in DPPC. At 4.8 mol% taxane (curve d), the
endotherm remained symmetric and was relatively less per-
turbed than DMPC under similar conditions. With further
increasing amounts of taxane prodrug to 9.1 and 16.7 mol%
(curves e and f), the DSC endotherms remain unchanged, as
was the case with C-6 taxane in DMPC at the same mol%
(Fig. 2 B). This suggests the point of saturation at higher
mol% by limiting solvation ability of the bilayers for the
acyl chain of the prodrug.
DSC endotherms for DPPC and C-16 taxane are shown in
Fig. 4 C. Similar to C-12 taxane, increasing C-16 taxane
content to 1 to 3 mol% abolished the pretransition and
broadened the main phase transition (curves b and c). As the
C-16 taxane concentrations were increased to 4.8 and 9.1
mol% (curves d and e), DPPC MLVs were relatively more
perturbed than for C-12 addition under similar conditions
(curves d and e; Fig. 4 B). At 9.1 mol% C-16 taxane, the
endotherm showed a high temperature shoulder, unlike the
C-12 taxane, possibly indicative of inhomogeneous mixing
or domain formation.
The effects of paclitaxel addition on
DSPC bilayers
The effects of paclitaxel addition on the thermotropic phase
behavior of DSPC were different than on DMPC and DPPC.
Fig. 5 shows endotherms of DSPC and paclitaxel mixtures.
DSPC alone showed a pretransition at 48.1°C (T1/2 
3.7°C and H  2.1 kcal/mol) and a main phase transition
(Tm) at 53.4°C (T1/2  0.5°C and H  11.5 kcal/mol).
Paclitaxel addition in the range of 1 to 9.1 mol% caused
insignificant changes in the pretransitions and main phase
transitions of the DSPC bilayers, except that the pretransi-
tions were broadened with increasing amounts of paclitaxel
(curves b-e). In addition, at paclitaxel concentrations as low
as 1 mol% a new phase appeared apart from the main phase
transition temperature at a lower temperature (Tm  1°C).
This peak is referred to as the twin peak, which arises from
the effects of osmotic stress on DSPC bilayers in the pres-
ence of sugars and salts (Perkins et al., 1997).
The effects of -bromoacyl taxane prodrugs
addition on DSPC bilayers
Unlike DMPC/C-6 and DPPC/C-6 taxane mixtures, the
addition of C-6 taxane caused little change in the shape of
the endotherms between 1 and 16.7 mol% (Fig. 6, curves
a-f), indicating that DSPC bilayers were less perturbed than
those composed of DMPC and DPPC (Figs. 2 A and 4 A,
curves a-f). The pretransition was evident at all mol%
values but was slightly shifted and broadened nearly to
baseline at 9.1 and 16.7 mol%, suggestive of little or insig-
nificant inclusion of the taxane into DSPC bilayers.
As illustrated in Fig. 6 B, DSPC/C-12 taxane mixtures
showed a similar behavior to DSPC/C-6 taxane mixtures
(Fig. 6 A). Thus, from 1 to 16.7 mol% C-12 taxane, the
endotherms (curves a-f) showed an insignificant broadening
of the main phase transition (T1/2  1°C) and near abol-
ishment of the pretransition.
DSPC and C-16 taxane binary mixtures behaved some-
what similarly to DSPC/C-12 taxane mixtures. Like C-12
taxane, the pretransition of DSPC was abolished at lower
C-16 taxane concentration (1 mol%), as was observed for
C-12 taxane (Fig. 6 C, curve b). The main phase transitions
were less perturbed and significantly less broadened
(T1/2  1°C; curves c-f).
The effects of paclitaxel and bromoacyl taxane
prodrugs on transition enthalpy (H)
In order to understand the interactions of PCs with pacli-
taxel and bromoacylated taxane prodrugs, we examined the
transition enthalpy (H) from each of the binary mixtures.
In general, except for DSPC, the H of DMPC and DPPC
was significantly lower for addition of paclitaxel compared
FIGURE 5 The DSC endotherms of binary mixtures of DSPC (Sigma)
with varying amounts (in mol%) of paclitaxel: 0 (curve a), 1 (curve b), 3
(curve c), 4.8 (curve d), and 9.1 (curve e). Arrow indicates appearance of
a distinct peak next to the main phase transition (Perkins et al., 1997).
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to taxane prodrugs in the concentration range investigated.
It is worth noting that there was a biphasic response in
transition enthalpy on paclitaxel or taxane prodrug additions
to PCs showed; at low paclitaxel concentrations (1–3 mol%)
H did not decrease, but did increase significantly with the
prodrugs at equivalent concentrations. However, there was a
decrease at 4.8 mol% with taxane, which reached a mini-
mum at or above 9.1 mol%.
Fig. 7 A shows the effects of addition of paclitaxel or
taxane prodrugs on the H of DMPC. Although there was
a decrease in H from 0 to 1 mol% paclitaxel, we think this
could be due to sample preparation. Paclitaxel addition at
concentrations ranging from 1 to 4.8 mol% did not result in
a significant change in the transition enthalpy of DMPC
(curve a, Fig. 7 A). However, as the paclitaxel concentration
increased to 9.1 mol% (the highest concentration used), the
H decreased by 20%. This decrease in H values sug-
gests that increasing amounts of paclitaxel in DMPC not
only perturbed the bilayers but also significantly reduced
the intermolecular interactions between bilayer interiors,
probably caused by the disruption of hydrogen bonding at
the lipid-water interface. In contrast, addition of taxane
prodrugs in the 1 to 3 mol% range, regardless of their acyl
chain lengths, caused relatively a higher H than paclitaxel.
This effect was more obvious with prodrugs bearing long
acyl chains. For example, H increased by 10% with
C-12 and C-16 taxanes (curve c and d), whereas it did not
increase significantly with C-6 (curve b) taxane prodrug at
FIGURE 6 The DSC endotherms of binary mixtures of DSPC with varying amounts (in mol%) of bromoacyl taxane prodrugs; 0 (curve a), 1 (curve b),
3 (curve c), 4.8 (curve d), 9.1 (curve e), and 16.7 (curve f). (A) DSPC and C-6 taxane; (B) DSPC and C-12 taxane; (C) DSPC and C-16 taxane mixtures.
FIGURE 7 The transition enthalpy, ‚H (kcal/mol) as a function of paclitaxel and taxane prodrug concentrations: Panel A: DMPC; Panel B: DPPC; Panel
C: DSPC; shown are paclitaxel (curve a, F with solid line), C-6 taxane (curve b, Œ with dashed line), C-12 taxane (curve c,  with — - — line), and C-16
taxane (curve d, E with solid line).
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lower concentrations. This change in H after addition of
taxanes suggests that long-chain taxane prodrugs associated
with bilayer hydrophobic residues better than short-chain
prodrugs. At concentrations 9.1 mol% with either taxane
prodrug, however, there was a plateau in the H, which
presumably reflects prodrug saturation in DMPC bilayers.
The effects of paclitaxel and taxane prodrugs on the H
of DPPC are shown in Fig. 7 B. Like DMPC/paclitaxel
mixtures, there was no significant change in H at lower
concentrations (1–4.8 mol%) of paclitaxel. However, at
higher paclitaxel concentrations, the transition enthalpy
started to decrease and it decreased by 20% at 9.1 mol%
of paclitaxel (curve a). A similar trend was also observed
for DMPC and paclitaxel binary mixtures as shown in Fig.
7 A (curve a). At low taxane concentrations, with increasing
amount of prodrugs from 1 to 4.8 mol%, there was a
continuous increase in H, but more so with long-chain
than short-chain taxane prodrugs. This increase in H sug-
gests that long-chain prodrugs increase the van der Waals
interactions by associating better with bilayer interiors than
do short-chain prodrugs. For instance, H at 4.8 mol% C-6
taxane prodrug (curve b) showed a less than 5% increase
compared to 20% increase with C-12 (curve c) and C-16
(curve d) taxane prodrugs. Similar to DMPC/taxane mix-
tures (Fig. 7A), at 9.1 mol% prodrug concentrations there
was a plateau in H, suggesting saturation of prodrugs in
DPPC bilayers.
Fig. 7 C shows the effects of paclitaxel and taxane
prodrugs addition on the H of DSPC. The transition en-
thalpy of DSPC after paclitaxel addition showed the same
trend as those of DMPC (Fig. 7 A) and DPPC (Fig. 7 B). At
low paclitaxel concentrations ranging from 1 to 4.8 mol%,
H remained constant or changed insignificantly. However,
at a higher paclitaxel content (9.1 mol%) in DSPC, the
transition enthalpy decreased by 10% (curve a, Fig. 7 C)
compared to a 20% decrease in DMPC and DPPC at
equivalent paclitaxel concentrations (curve a, Figs. 7, A and
B). In contrast to C-6 taxane prodrug, C-12 and C-16
prodrugs showed a similar H profile for the addition in
DSPC as those observed for DMPC and DPPC. The H
value did not change significantly with C-6 taxane at low
prodrug concentrations (1–4.8 mol%), while it increased by
5 to 10% with C-12 and C-16 taxanes at equivalent
concentrations. With increasing amounts of C-6 taxane, H
showed somewhat a similar decreasing trend as those of
C-12 and C-16 taxane prodrugs before attaining a plateau at
higher taxane contents (Fig. 7 C, curves c and d). This again
may indicate the point of saturation of the hydrophobic core
of the PCs with paclitaxel or taxane prodrugs.
Taxane prodrug association with
phosphocholine bilayers
DSC data, as shown in Figs. 1, 3, and 5, suggest that
paclitaxel lacking the hydrophobic residue is least associ-
ated with the lipid bilayers, presumably due to lack of its
penetrating ability. Alternatively, degree of insertion of the
taxane prodrugs bearing short and long acyl chains attached
to paclitaxel with PC bilayers varied depending upon their
hydrophobic chain lengths. The DSC data indicate that the
long-chain C-16 taxane prodrug was associated with PCs
better than the short-chain taxane prodrugs (C-6 and C-12
derivatives), as indicated by the perturbation on the lipid
bilayers. We selected C-16 taxane prodrug to examine the
prodrug’s association with the PC bilayers. Thus, we pre-
pared DMPC, DPPC, and DSPC binary mixtures with C-16
taxane prodrug at a maximal concentration of 16.7 mol%
used in the experiments. The fractions from the sucrose
gradient column were analyzed for their taxane and phos-
pholipid contents (data not shown), and the ratios of the two
were estimated. It was found that first few liposomal frac-
tions contained 5 to 6 mol% of C-16 taxane prodrug. Fig.
8 exhibits the endotherms of pooled liposomal fractions of
PC/taxane mixtures. It was obvious from the endotherms
that taxane prodrug as high as 16.7 mol% in all three PCs
abolished the pretransition and significantly broadened the
main phase transition of each of the PCs in the order:
DMPC  DPPC  DSPC. These endotherms support the
DSC data for the PCs examined in Figs. 2, 4, and 6. From
these data it was apparent that association of acylated taxane
prodrug was independent of the amount of taxane addition.
It can also be suggested that taxane ring was being excluded
from intercalating into bilayer because of its bulky size, as
was the case with paclitaxel and PC mixtures (Figs. 1, 3, and
5). Thus, it is tempting to speculate that the amount of C-16
FIGURE 8 DSC endotherms of C-16 taxane prodrug associated with
DMPC (curve a), DPPC (curve b), and DSPC (curve c) liposomes obtained
after sucrose gradients.
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taxane prodrug would have been greater than 5 to 6 mol%
if the bulky taxane had been fully incorporated into PC
bilayers. Furthermore, the perturbation of main phase tran-
sition, most notably in DMPC and DPPC with shoulders at
low and high temperatures, indicates the intercalation of
prodrug’s acyl chain into PC, which may result in an inho-
mogeneous mixing and possibly the phase separation
(Fig. 8).
DISCUSSION
The DSC results demonstrate that the chain lengths of
acylated taxane prodrugs play an important role in the
mixing behavior of the derivatives with phosphocholines
varying in acyl chain composition. For instance, taxane
prodrugs with long chains are incorporated relatively effec-
tively into the short-chain bilayers. In contrast, the short-
chain taxane prodrugs are incorporated relatively poorly
into the long-chain bilayers. Thus, the acyl chain composi-
tion of the lipid matrix plays an important role in the
solvation ability of the taxane prodrugs varying in acyl
compositions. The DSC data for PCs mixed with acylated
taxane prodrugs clearly showed that the gel-to-liquid crys-
talline lamellar phase transition was shifted to lower tem-
peratures and broadened as the taxane prodrug content
increased. The effect was more pronounced with DMPC
than DPPC or DSPC. These effects possibly result from
intercalation of the taxane acyl chains into phospholipid
bilayers in order to maximize the van der Waals interac-
tions. The depth of acyl chain penetration into the bilayers
remains unknown at present. However, the DSC data (Figs.
2 and 4) suggest that the C-16 chain of the taxane derivative
could span the entire width of PC monolayer in liposomes.
This type of association perturbs the phospholipid bilayers
as observed by a decrease in the onset and an increase in
completion temperatures of the L phase. As shown in Figs.
2 A and 4 A, the C-6 taxane had limited access to the
hydrophobic interiors of the PC compared to C-12 and C-16
taxane prodrugs and the amount of association was greater
with the long-chain compared to the short-acyl chain pro-
drugs. At 9 mol% or greater C-16 taxane prodrug concen-
trations in DMPC and DPPC, the bilayers perturbation was
larger with C-16 taxane than those with C-6 and C-12
taxane prodrugs. Thus, a taxane prodrug with a longer chain
could intercalate more deeply into the bilayer.
Taxane prodrug addition to DSPC bilayers resulted in
apparent anomalous behavior compared to those of DMPC
and DPPC as observed by only a slight change in the shape
of the endotherms on taxane addition. This was, in part, due
to a stronger intermolecular hydrophobic chain interaction
than DMPC and DPPC. Increasing amounts of taxane pro-
drugs in all the PCs examined may form taxane-rich mi-
crodomains, which are undetectable in the endotherms,
within the temperature range investigated. This can also
suggest that paclitaxel alone or prodrugs may sequester at
the water-lipid interface in the MLVs. Another possibility is
that taxanes could form micelles or emulsions with phos-
pholipids, which are not detectable under the DSC condi-
tions. Such structures have been reported for taxane pro-
drugs associated with PEG-lipids in high drug/lipid ratios
(Perkins et al., 1999). It can be argued that the lipid bilayers
have limited ability to solubilize paclitaxel because of bulky
size of the taxane ring. Interestingly, the H decrease of the
PCs after paclitaxel addition at low and higher concentra-
tions may not be associated with the intercalation of the
molecule into bilayer interiors since symmetric and sharp
endotherms were apparent at those concentrations. A simi-
lar decrease in H was also found with prodrugs bearing
hydrophobic moieties regardless of the acyl chain compo-
sition at higher drug lipid molar ratios. It is possible that
accumulation of paclitaxel or taxane prodrugs at the bilayer
surface, undetectable by DSC, may disrupt hydrogen bond-
ing at the surface between the lipid molecules by diminish-
ing the intermolecular interaction capabilities. However,
DSC can not detect such a change. From the H data it is
also apparent that paclitaxel at low concentrations in PCs
showed an anomalous behavior compared to taxane pro-
drugs. For example, PCs containing 1 to 4.8 mol% of
taxane, showed the H 20% increase for DMPC and
DPPC and 5 to 10% for DSPC. This increase in H
indicates that there is a strong chain-chain interaction be-
tween prodrug and PC, presumably as a result of the taxane
prodrug’s acyl chain partitioning into the bilayer. Recently,
Lehtonen et al. (1996) have shown that a heterocyclic daid-
zein compound, a protein tyrosine kinase inhibitor, when
interacting with DMPC or DPPC, caused a 15% decease
in H values, albeit at higher concentrations than taxane,
probably due to the smaller size of the molecule. Our data
are consistent with the findings that solutes show preference
for the low-temperature gel phase lipids possessing hydro-
phobic chain lengths approximately the same as the bilayer
acyl chain lengths (McMullen and McElhaney, 1995).
Recently, Baemark et al. (1997) have shown that an
amphiphilic polymer, DC18PEO45, had H profile with
PC’s similar to those observed with the taxanes on PCs.
Accordingly, at low polymer concentrations (3–5 mol%),
H increased as the polymer concentration increased, fol-
lowed by a 26% decrease at higher concentrations, a
phenomenon similar to those observed in taxane/PC mix-
tures (Fig. 7). This H increase is primarily due to an
ordering effect of the polymer in forcing part of the mole-
cule to align into the bilayer interior (Baemark et al., 1997).
As the polymer concentrations increased to 10 mol% or
higher, the polymer was forced to the exterior at the water-
lipid interface with little or no change in the phase transi-
tions of PC. It is clear from our data that dehydration or
osmotic stress did not shift the phase transition of the
mixtures to a higher temperature. Indeed there was a slight
shift in PC’s phase transition to a lower temperature, which
was more noticeable at lower taxane than at higher taxane
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prodrug concentrations. It is possible that intermolecular
interactions may be diminished by the disruption of hydro-
gen bonding and with promotion of electrostatic interactions
between the taxanes and lipid molecules at the water-lipid
interface. A slight phase transition shift and a constant H
at higher concentrations suggest that the hydrophobic core
of the PC bilayers are saturated with prodrugs. Ruocco and
Shipley (1983) have shown that mixing DPPC bilayers with
cerebrosides at concentrations beyond 23 mol% promotes
the formation of clusters, by partial trapping of the phos-
pholipid molecules in laterally segregated glycolipid do-
mains. This domain formation results in a decrease in H of
the phospholipid-rich gel-to-fluid phase transition at higher
cerebroside concentrations. We observed a similar H de-
crease of the phospholipid-rich gel-to-liquid phase transi-
tion at higher concentrations of paclitaxel or taxane prodrug,
which may be indicative of clustering or aggregation of the
taxanes with and without acyl chains at the membrane
surface.
It can be suggested that fluid-type or thin bilayers (e.g.,
DMPC) could solvate a larger percentage of taxane com-
pared with gel-type bilayers (DPPC or DSPC). Thus, the
extent of solvation of taxane into lipid bilayers may be a
result of a balance between the type of lipid assembly and
the orientation of the taxane hydrophobic residues. Our
phosphocholines and taxane prodrugs DSC data supports
the results of another study (Balasubramanian and Straub-
inger, 1994) where non-acylated paclitaxel had a limited
access into DPPC bilayers because of the bulky taxane ring,
as also we showed in Fig. 3. We found that it was also true
for paclitaxel mixed with short-chain DMPC and long-chain
DSPC (Figs. 1 and 5). In essence, having a prodrug with an
acyl chain and a lipid with low chain melting temperature
may facilitate association of the taxane with bilayers
through anchoring of the taxane hydrophobic chain in the
bilayers. This was indeed the case with C-16 taxane/PC
liposomes, which showed 5 to 6 mol% of taxane
incorporation.
Implications
The lipophilicity and poor water solubility of antineoplastic
taxane prodrugs provide an opportunity to examine the
lipid-prodrug interactions in the model membranes (lipid
formulations), where the hydrophobic residues of the pro-
drug can be anchored into the bilayer interiors. The DSC
technique used in this study helps understand drug solubi-
lization in lipid assemblies. The DSC data can help identify
and, to some extent, solve problems associated with drug
induced changes in lipid assemblies, and provide informa-
tion about concentration-dependent exclusion of drugs from
bilayers. Importantly, this study provides evidence that tax-
ane prodrugs bearing hydrophobic moieties varying in chain
length may prefer one lipid matrix over others, due to
lipid-specific selective solvation. It has been shown previ-
ously that association of paclitaxel with liposomes reduces
acute toxicity while maintaining anticancer activity in ani-
mals (Sharma et al., 1993, 1997), and it can therefore be
suggested that association of acylated taxane prodrugs with
liposomes may have similar effects. DSC alone can not
determine how a drug is oriented in the lipid bilayer matrix
and how the acyl chain composition of the taxane modulates
the taxane-lipid interactions. The therapeutic utility of tax-
ane prodrugs formulated in lipid membrane remains to be
established, although these taxane prodrugs are therapeuti-
cally active in vivo when formulated in Cremophor EL
(Ahmad et al., 1997). The DSC data, however, show that
phospholipids having variable acyl compositions accommo-
date certain amounts of drug dependent upon the taxane
acyl composition and that prodrugs with long acyl chains
associate better than those with short chains. This study also
suggest that other phospholipids with structures different
than disaturated DMPC, DPPC, and DSPCs may be of value
in formulating taxane prodrugs and other acylated drugs.
For example, lipids that form interdigitated assemblies or
have bilayer defects due to unsaturation could be used in
formulating some drugs. However, much further study is
needed for a full understanding of taxane interactions with
lipid bilayers.
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